[{"NetIncomeLoss_3_Q3_USD":-18213000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":3251000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-22114000.0,"Depreciation_3_Q3_USD":131000.0,"AssetsCurrent_0_Q3_USD":251915000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":75000.0,"CommonStockSharesIssued_0_Q3_shares":40016792.0,"Assets_0_Q3_USD":274249000.0,"ShareBasedCompensation_3_Q3_USD":1237000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":231000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":189825000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":609000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":10102000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"OperatingIncomeLoss_3_Q3_USD":-18424000.0,"InterestAndOtherIncome_1_Q3_USD":15000.0,"InterestAndOtherIncome_3_Q3_USD":35000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":464000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":39957000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2532000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":176000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":176000.0,"CommonStockValue_0_Q3_USD":40000.0,"DepositContractsAssets_0_Q3_USD":9204000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":43000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":192341000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":221000.0,"OperatingIncomeLoss_1_Q3_USD":-9753000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1434000.0,"OtherAssetsNoncurrent_0_Q3_USD":199000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":241524000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":164000.0,"Liabilities_0_Q3_USD":6684000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":3953000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":1712000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":39218000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":90000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":1299000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":274249000.0,"ProceedsFromWarrantExercises_3_Q3_USD":692000.0,"LiabilitiesCurrent_0_Q3_USD":6326000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":148018000.0,"AccountsPayableCurrent_0_Q3_USD":2345000.0,"OtherCommitment_0_Q3_USD":1900000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":10391000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1824000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":1209000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-22209000.0,"AdditionalPaidInCapital_0_Q3_USD":460659000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q3_shares":4898.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":1209000.0,"OperatingLeasePayments_3_Q3_USD":68000.0,"OperatingLeasePayments_1_Q3_USD":41000.0,"PrepaidInsurance_0_Q3_USD":966000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":20695000.0,"NetIncomeLoss_1_Q3_USD":-9562000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":267565000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":464000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":null,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":217000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":126000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":1237000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":572000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":20912000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":95000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":206000.0,"OperatingExpenses_3_Q3_USD":18424000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q3_USD":null,"OperatingExpenses_1_Q3_USD":9753000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.24,"OtherLiabilitiesNoncurrent_0_Q3_USD":194000.0,"OtherLiabilitiesCurrent_0_Q3_USD":509000.0,"StockholdersEquity_0_Q3_USD":267565000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":22114000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-193134000.0,"CommonStockSharesOutstanding_0_Q3_shares":40016792.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":165000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.46,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":90000.0,"Ticker":"SAVA","CIK":"1069530","name":"CASSAVA SCIENCES INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211115"}]